ArticleIntensive care medicine experimental2019

Adrecizumab, a non-neutralizing anti-adrenomedullin antibody, improves haemodynamics and attenuates myocardial oxidative stress in septic rats.

Alice Blet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.